Digital Biomarkers Solution shows pathway to reduced clinical trial sample sizes, shorter durations


Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.

© 2024 MJH Life Sciences

All rights reserved.